Designing hospital pharmacies that complying with current U.S. Pharmacopeial Convention (USP) 797 sterile compounding regulations will require planning, time and funding, according to an article on the Health Facilities Management website.
Understanding where a healthcare facility stands relative to the regulations, and engaging stakeholders in the process will ensure success, according to the article.
USP 797 focuses on maintaining a safe environment for preparing patient-specific medications that must be prepared in a sterile environment and remain sterile when administered.
Compliance can be time-consuming and expensive. Unlike other capital expenditures, investment in USP 797 compliance does not generate increased revenue.
AI Adoption on the Rise Among Leaders
TriasMD Officially Opens DISC Surgery Center at Tarzana
Goshen Health Announces Partnership with Parkview Health
Severe Winter Weather: What Healthcare Facilities Must Prioritize
Recovery Centers of America Opens New Facility in Florida